Breaking: Byju's appoints TV Mohandas Pai and Rajnish Kumar to advisory panel, Arjun Mohan to lead international business.
One quick thing: Google's AI chatbot Bard now supports 9 Indian languages and introduces several new features.
In today’s newsletter:
Was this newsletter forwarded to you? You can sign up for Tech3 here
K Krithivasan, the recently appointed CEO of Tata Consultancy Services, expressed his deep affection for his hometown, reminding us of the popular Tamil song "Namma Chennai Chancey Illa" (which roughly means there is no place like Chennai)
But the Chennaite faces a challenging road ahead as clients exercise caution in uncertain times.
Krithivasan admitted that it would be difficult to achieve double-digit growth for TCS this year amid a weak macro environment. He also said it would take at least a quarter or two before the company can confidently put difficult times behind it.
Krithivasan, who has been meeting with clients globally, expects growth momentum to return once uncertainty ends in major markets.
Despite the challenges, Krithivasan remains confident that TCS can meet its margin band target of 26-28%.
TCS CEO sees "nation building" as more important than profit margins in government projects.
Citing the recent deal with BSNL to deploy 4G networks across India, Krithivasan said that the company does not solely focus on making money from government projects, but sees it as an opportunity for 'nation-building.'
Moving on from India’s largest IT company to the fourth-largest IT firm which reported its Q1 results today.
Wipro's headcount has fallen for the third consecutive quarter, with the company ending the quarter with nearly 9,000 fewer employees than the previous quarter. This is happening even as attrition has continued to trend downward.
Why is this important? Hiring is an indicator of demand, and the decline in demand has impacted the entire IT industry.
In fact, the company has been facing the ire of fresh graduates who have been waiting over a year to be onboarded. Wipro has maintained that it will onboard new employees as needed. However, in Q1FY24, it did not onboard any of the graduates who are still waiting.
On the numbers front, Wipro’s figures were down — as expected.
Wipro's revenue growth guidance for the next quarter is -2% to 1% in constant currency, and it expects to be in a similar margin range.
The softness in demand continues to impact the company, as seen by the decline across its geographies and impacted verticals such as BFSI (banking, financial services, and insurance), consumer, and communications.
Smaller discretionary spends have also been postponed or stopped, and the market remains as uncertain as it was a quarter ago.
From large fintech platforms like PhonePe to new-age startups like Jar, everyone wants a big piece of the digital lending pie. The market is growing rapidly, and here are some reasons why.
The growing optimism about digital lending coincides with a significant increase in loan disbursement.
In addition, lending-focused companies have dominated startup funding this year, attracting approximately one-third of overall investments.
Apart from the fact that India has a credit-starved market, there are other significant tailwinds.
On July 13, 1992, IBM, Toshiba, and Siemens announced a joint venture to develop memory chips for computers. This was a significant departure from the norm in the semiconductor industry, which had traditionally been characterised by fierce competition between companies.
Artificial intelligence (AI) is changing the world, and healthcare is no exception.
Introducing Google's Med-PaLM 2, an AI tool that can answer questions about medical information. It has been in testing at the Mayo Clinic research hospital, and while it still has some accuracy issues to address, it matches or even surpasses human doctors in nearly every other metric.
As we stand on the cusp of this transformative shift, questions naturally arise. Can we truly entrust our health to an AI doctor?
Med-PaLM 2 is still under development, but it has the potential to revolutionize the way we diagnose and treat diseases. The technology could provide 24/7 healthcare and access to medical expertise in remote areas. Find out more (Picture credit: DALL-E)
Note: By subscribing to Tech3 you have already made the right choice. Top it up with a premium offering, the Moneycontrol Pro Panorama, a newsletter that gives you a sharp take on macros, markets, business and finance. Sign up for Pro from this link to get this newsletter in your inbox and also a host of content enjoyed by 500,000+ subscribers.